Joko Widodo
This past week, from February 7-13, 2026, marked a truly extraordinary period in the venture capital landscape, characterized by an unprecedented concentration of mega-rounds that underscored robust investor confidence in transformative technologies. The collective sum of capital deployed into U.S.-based startups reached staggering figures, signaling a dynamic and resilient market, particularly within the realms of artificial intelligence, advanced robotics, and deep tech. Leading this monumental surge was generative AI pioneer Anthropic, whose colossal $30 billion Series G round not only dominated headlines but also set new benchmarks for venture financing, propelling a week defined by ambitious visions and significant financial backing for companies poised to reshape industries. Beyond AI, sectors such as fusion energy, commercial space exploration, and innovative healthcare solutions also attracted substantial investments, painting a vivid picture of a venture ecosystem thriving on innovation and long-term potential.
The week’s funding activity was headlined by a single, seismic event: Anthropic’s staggering $30 billion Series G funding round. This monumental investment valued the San Francisco-based generative AI powerhouse at an eye-watering $380 billion post-money, instantly making it the largest venture funding deal of 2026 to date and the second-largest of all time, according to Crunchbase data. The sheer scale of this financing speaks volumes about the current fervor surrounding generative AI and Anthropic’s perceived position at the forefront of this revolution. The company, known for its Claude family of AI models, is a formidable competitor to OpenAI and Google, emphasizing safety and interpretability in its AI development. This massive capital injection, co-led by an impressive consortium of institutional giants including GIC, Coatue, D.E. Shaw & Co. Ventures, Dragoneer Investment Group, Founders Fund, Iconiq Capital, and MGX, provides Anthropic with unparalleled resources to accelerate its research, development, and commercialization efforts. It allows the company to deepen its foundational AI models, expand its talent pool, and potentially explore new application areas, solidifying its strategic advantage in a rapidly evolving and intensely competitive market. The valuation itself reflects not just current achievements but immense future expectations, positioning Anthropic as a pivotal player in shaping the future of artificial intelligence and its integration across global industries.
Following Anthropic’s groundbreaking raise, Apptronik secured a substantial $520 million in new financing. This investment represents an extension to its earlier $415 million Series A round from February 2025, bringing the total for this crucial Series A to an impressive $935 million. Based in Austin, Texas, Apptronik is at the cutting edge of AI-powered robotics, specifically focusing on humanoid robots. The significant capital infusion highlights the burgeoning interest and growing confidence in the commercial viability and transformative potential of humanoid robotics. These versatile machines are envisioned to tackle a wide range of tasks, from industrial automation and logistics in challenging environments to potentially assisting in healthcare or even domestic settings. With this enhanced funding, Apptronik is well-positioned to accelerate the development, testing, and eventual deployment of its advanced humanoid platforms, moving from prototypes to scalable, market-ready solutions. The investment underscores a broader trend where robotics, once confined to specialized industrial applications, is now expanding into more general-purpose and human-centric roles, driven by advancements in AI and mechanical engineering.
The deep tech sector continued to attract significant capital, with Inertia Enterprises raising $450 million in Series A funding for its fusion energy endeavors. This Livermore, California-based startup, only two years old, is focused on developing commercially viable fusion power – a holy grail in the quest for clean, limitless energy. The round was spearheaded by Bessemer Venture Partners, with additional backing from prominent investors such as Google Ventures and Threshold. Fusion energy promises to unlock a carbon-free, virtually inexhaustible power source by replicating the process that powers the sun. While still a long-term prospect, the recent surge in private investment in fusion startups like Inertia Enterprises indicates a growing belief that technological breakthroughs are bringing this vision closer to reality. Investors are increasingly willing to commit substantial capital to companies working on these capital-intensive, long-horizon projects, recognizing the immense potential societal and economic returns if successful. Inertia’s Series A signals a strong vote of confidence in its specific approach and technological roadmap to harness the power of fusion.
In the rapidly expanding new space economy, Axiom Space secured $350 million in new financing. Headquartered in Houston, a city steeped in space history, Axiom Space is not merely a participant but a trailblazer in commercial space exploration. The company has ambitious plans to build the world’s first commercial space station, intended to succeed the International Space Station (ISS), and is also developing advanced spacesuits for future moon missions. This funding round, led by Type One Ventures and Qatar Investment Authority, underscores the global strategic importance and economic potential of privatizing and commercializing space infrastructure. Axiom Space’s vision involves providing commercial and government astronauts with access to space, fostering microgravity research, and enabling in-space manufacturing. The investment will accelerate the development of its modular space station segments and advanced extravehicular activity (EVA) suits, positioning Axiom Space as a key player in shaping humanity’s continued presence in low Earth orbit and beyond.
The generative AI trend extended beyond foundational models into creative applications, as Runway picked up $315 million in a Series E round. This financing round catapulted the New York-based AI research and technology startup to a $5.3 billion valuation, a significant jump from its $3.3 billion valuation just last April. General Atlantic led the investment, recognizing Runway’s pivotal role in the burgeoning field of AI-powered video generation and editing. Runway provides innovative tools that enable creators to generate, edit, and manipulate video content using artificial intelligence, democratizing complex visual effects and accelerating creative workflows. Its platform is widely used by artists, filmmakers, and content creators, pushing the boundaries of what’s possible in digital media production. This substantial funding will allow Runway to further enhance its AI models, expand its suite of creative tools, and solidify its position as a leader in the evolving landscape of AI-driven content creation, ultimately transforming how visual stories are told.
The healthcare sector also saw significant investment, reflecting ongoing demand for improved access and efficiency. Talkiatry, a New York-based provider of in-network psychiatry services, raised $210 million in Series D funding. This round, led by Perceptive Advisors, brings Talkiatry’s total funding to date to over $400 million, highlighting the pressing need for accessible mental health solutions. Talkiatry addresses a critical gap in the healthcare system by connecting patients with qualified psychiatrists who accept insurance, thereby removing significant barriers to care. The company partners with health systems and employers to integrate its services, ensuring that individuals can receive timely and affordable psychiatric support. This substantial investment will enable Talkiatry to expand its network of providers, enhance its technological platform, and reach more patients across the country, tackling the growing mental health crisis with scalable and integrated solutions.
Continuing the healthcare investment trend, Solace Health, based in Redwood City, California, secured $130 million in Series C funding. This round, led by IVP, pushed the four-year-old company’s valuation past the $1 billion mark, officially granting it unicorn status. Solace Health operates a digital platform designed to connect patients with expert healthcare advocates. In an increasingly complex healthcare system, navigating insurance claims, understanding medical bills, and coordinating care can be overwhelming for patients. Solace Health aims to simplify this process by providing personalized advocacy, helping individuals make informed decisions and access the best possible care. The investment underscores the market’s recognition of the value in patient-centric support services that reduce friction and improve outcomes within the healthcare ecosystem. This capital will allow Solace Health to scale its platform, expand its network of advocates, and reach a wider audience of individuals seeking guidance through their healthcare journeys.
Another significant healthcare investment was seen with Garner Health, which raised $118 million in Series D financing. The New York-based company offers a digital platform that empowers patients to find high-quality healthcare providers tailored to their specific needs. Led by Kleiner Perkins, this funding round reflects the ongoing challenge patients face in identifying effective and appropriate medical care, often relying on incomplete information or word-of-mouth. Garner Health leverages data and analytics to help users connect with top-performing doctors and specialists, aiming to improve healthcare outcomes and reduce unnecessary costs. The investment will enable Garner Health to further develop its proprietary algorithms, expand its network of vetted providers, and enhance its user experience, ultimately making it easier for individuals and employers to navigate the fragmented healthcare landscape and make better choices about their medical care.
Rounding out the week’s top funding rounds, two companies tied for ninth place, each securing $100 million.
First, Simile, a Palo Alto, California-based startup, closed a $100 million Series A funding round led by Index Ventures. Simile is focused on the cutting-edge application of AI to create highly realistic simulated environments and advanced simulation tools featuring intelligent AI agents. This technology has profound implications across various industries, from training autonomous systems (like self-driving cars or robots) in virtual worlds to developing complex industrial simulations and even creating more immersive and dynamic digital experiences. The investment highlights the growing demand for sophisticated simulation capabilities that can accelerate development cycles, reduce real-world testing costs, and enable safer, more efficient innovation. With this capital, Simile plans to expand its research and engineering teams, further refine its AI simulation platform, and explore new markets for its transformative technology.
Tying with Simile, Loyal secured $100 million in Series C funding. This San Francisco-based company, seven years in the making, is dedicated to a unique mission: developing drugs to extend the healthy lifespans of senior dogs. The round, led by venture fund Age1, provides Loyal with the necessary capital to transition its innovative products from late-stage development to market readiness. As pets become increasingly integral parts of families, the demand for advanced veterinary care and solutions that improve animal welfare and longevity is soaring. Loyal’s focus on extending healthy lifespans addresses a significant market need and taps into the growing field of geroscience, applying scientific advancements to combat aging. This investment underscores investor confidence in Loyal’s scientific approach and its potential to revolutionize pet care, offering a longer, healthier life for beloved canine companions.
This week’s unprecedented funding activity, particularly the landmark Anthropic round, underscores several key trends dominating the venture capital landscape in early 2026. The continued explosion of interest and investment in artificial intelligence, especially generative AI, remains the most prominent narrative. Beyond AI, significant capital flowed into deep tech sectors like robotics, fusion energy, and commercial space, indicating a long-term strategic focus on technologies with the potential for monumental societal impact, even if their commercialization timelines are extended. The healthcare sector also demonstrated resilience, attracting substantial funding for solutions addressing access, advocacy, and provider search. Geographically, California and New York continue to serve as vibrant hubs for innovation, attracting the lion’s share of mega-deals. The sheer volume and scale of these rounds collectively signal a robust and optimistic outlook for venture capital, with investors keen to back disruptive companies poised to define the next era of technological advancement and economic growth. This powerful start to the year suggests that 2026 could be a landmark year for startup funding, as outlined in ongoing tracking efforts like the Crunchbase Megadeals Board.
